| Year |
Citation |
Score |
| 2023 |
Magoling BJA, Wu AY, Chen YJ, Wong WW, Chuo ST, Huang HC, Sung YC, Hsieh HT, Huang P, Lee KZ, Huang KW, Chen RH, Chen Y, Lai CP. Membrane Protein Modification Modulates Big and Small Extracellular Vesicle Biodistribution and Tumorigenic Potential in Breast Cancers in vivo. Advanced Materials (Deerfield Beach, Fla.). e2208966. PMID 36609913 DOI: 10.1002/adma.202208966 |
0.73 |
|
| 2022 |
Chen HY, Chan SJ, Liu X, Wei AC, Jian RI, Huang KW, Lang YD, Shih JH, Liao CC, Luan CL, Kao YT, Chiang SY, Hsiao PW, Jou YS, Chen Y, et al. Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression. Journal of Hematology & Oncology. 15: 85. PMID 35794621 DOI: 10.1186/s13045-022-01306-3 |
0.499 |
|
| 2022 |
Cheng HT, Huang HC, Lee TY, Liao YH, Sheng YH, Jin PR, Huang KW, Chen LH, Chen YT, Liu ZY, Lin TC, Wang HC, Chao CH, Juang IP, Su CT, ... Huang KH, et al. Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 346: 169-179. PMID 35429575 DOI: 10.1016/j.jconrel.2022.04.004 |
0.726 |
|
| 2021 |
Song JS, Chang CC, Wu CH, Dinh TK, Jan JJ, Huang KW, Chou MC, Shiue TY, Yeh KC, Ke YY, Yeh TK, Ta YN, Lee CJ, Huang JK, Sung YC, et al. A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33753481 DOI: 10.1073/pnas.2015433118 |
0.778 |
|
| 2020 |
Huang KW, Hsu FF, Qiu JT, Chern GJ, Lee YA, Chang CC, Huang YT, Sung YC, Chiang CC, Huang RL, Lin CC, Dinh TK, Huang HC, Shih YC, Alson D, et al. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Science Advances. 6: eaax5032. PMID 31998834 DOI: 10.1126/Sciadv.Aax5032 |
0.537 |
|
| 2018 |
Huang KW, Lai YT, Chern GJ, Huang SF, Tsai CL, Sung YC, Chiang CC, Hwang PB, Ho TL, Huang RL, Shiue TY, Chen Y, Wang SK. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma. Biomacromolecules. PMID 29808997 DOI: 10.1021/Acs.Biomac.8B00358 |
0.698 |
|
| 2017 |
Liu CH, Chern GG, Hsu FF, Huang KW, Sung YC, Huang HC, Qiu JT, Wang SK, Lin CC, Wu CH, Wu HC, Liu JY, Chen Y. A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia. Hepatology (Baltimore, Md.). PMID 28885731 DOI: 10.1002/Hep.29513 |
0.748 |
|
| Show low-probability matches. |